3 results
Approved WMOCompleted
To evaluate safety of 3-months versus standard 12-months of DAPT
Approved WMOCompleted
To assess the safety, efficacy and net clinical benefit of clopidogrel versus the new antiplatelet drugs i.e. ticagrelor and prasugrel in patients older than 70 years.
Approved WMOCompleted
To assess the efficacy, safety and cost-effectiveness of the CYP2C19 genotype guided antiplatelet treatment strategy, using clopidogrel or prasugrel/ticagrelor.